Since joining Tau Medical in 2017, Yeongjae Lee has played a pivotal role in driving the company’s growth across multiple operational and strategic domains. Drawing on more than two decades in the heart-health arena, he brings a uniquely broad perspective to his role as Clinical Director, where he now oversees corporate operations, sales and marketing, and external relations.

 

Prior to Tau, Yeongjae led projects from early R&D through full commercialization of heart-focused medical devices, managing diverse business development functions and sharpening both technical expertise and market insight. Throughout that journey he cultivated strong, trust-based relationships with Korea’s clinical heart-care community, providing Tau privileged insight into real-world needs and adoption pathways.

 

Yeongjae’s versatility and cross-functional leadership have been instrumental in advancing Tau’s mission and in steering the company through the regulatory and commercial challenges unique to structural-heart technologies. His ability to align internal teams with key external stakeholders continues to position Tau Medical as a dynamic innovator in this field.

​

​